Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

Ecosim flow diagram for Scenario 1.2. by Elizabeth R. Gillie (7357796)

“…We further show that increasing capelin with a simultaneous decrease in Arctic cod biomass causes large decreases in the biomass of marine mammals such as polar bear, beluga and ringed seal. …”

Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx by Le Zhang (88249)

Characteristics of participating licensed premises. by Eleni Mantzari (6991172)

Subjects:

Flow of premises through the study. by Eleni Mantzari (6991172)

Subjects:

Change in daily volume of beer sold (% (95% CI) with intervention. by Eleni Mantzari (6991172)

Subjects:

Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ_<i>S</i> paramete... by Keith Fraser (1868587)

PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predat... by Alexandra M. Campbell (3284094)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Data Sheet 1_Correlation analysis of osteoporosis and vertebral endplate defects using CT and MRI imaging: a retrospective cross-sectional study.pdf by Song Hao (5700608)

“…The vertebral Hounsfield unit (HU) value and the maximum width and maximum depth of the vertebral endplate defect were measured and standardized. …”

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Phylogenetic analysis of <i>Anaplasma</i> spp. based on the partial 16S rRNA gene sequence. by Sumaira Sumaira (21453523)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Overall comparison of <i>Anaplasma</i> spp. and <i>A. ovis</i> prevalence among the goats enrolled from three districts in Punjab during the present study. % prevalence is given in... by Sumaira Sumaira (21453523)

Flow chart. by Abed al Hadi Krisht (19704098)

“…</p><p>Objective</p><p>The objectives of this study were to measure the prognostic value of the extent of lung parenchymal lesions on computed tomography (CT) and of several coagulation and inflammatory biomarkers, and to explore the characteristics of the patients depending on the extent of lung parenchymal lesions.…”